Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

602 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A cluster-randomised controlled feasibility trial evaluating the Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS).
Hynes SM, Dwyer CP, Alvarez-Iglesias A, Rogers F, Joyce RA, Oglesby MH, Moses A, Bane E, Counihan TJ, Charamba B; COB-MS PPI Advisory Panel 1. Hynes SM, et al. Among authors: rogers f. Neurol Sci. 2025 Jan;46(1):445-462. doi: 10.1007/s10072-024-07757-5. Epub 2024 Sep 24. Neurol Sci. 2025. PMID: 39313688 Free PMC article. Clinical Trial.
Comparing the effects of a patient-designed-and-informed participant information leaflet in comparison with a standard, researcher-designed information leaflet on recruitment, retention and understanding: A study-within-a-trial.
Dwyer CP, Joyce RA, Rogers F, Hynes SM. Dwyer CP, et al. Among authors: rogers f. Contemp Clin Trials Commun. 2022 Jun 2;28:100936. doi: 10.1016/j.conctc.2022.100936. eCollection 2022 Aug. Contemp Clin Trials Commun. 2022. PMID: 35711678 Free PMC article.
Practices affEcting macitentan and selexipag patient persistence Rates utilizing pulmonary arterial hypertension clinical Site and patIent perSpecTives (PERSIST): a US qualitative analysis.
Shlobin OA, Bruce G, Gomez-Rendon G, Kingman M, Rahman M, Rogers F, Studer S, Tobore T, McEvoy C. Shlobin OA, et al. Among authors: rogers f. Pulm Circ. 2024 Oct 11;14(4):e12441. doi: 10.1002/pul2.12441. eCollection 2024 Oct. Pulm Circ. 2024. PMID: 39398324 Free PMC article.
Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition.
Rackear M, Quijano E, Ianniello Z, Colón-Ríos DA, Krysztofiak A, Abdullah R, Liu Y, Rogers FA, Ludwig DL, Dwivedi R, Bleichert F, Glazer PM. Rackear M, et al. Among authors: rogers fa. Oncotarget. 2024 Oct 1;15:699-713. doi: 10.18632/oncotarget.28651. Oncotarget. 2024. PMID: 39352803 Free PMC article.
602 results